Aditxt (NASDAQ:ADTX) Major Shareholder Financial Lp Hrt Acquires 843,622 Shares

Aditxt, Inc. (NASDAQ:ADTX) major shareholder Financial Lp Hrt acquired 843,622 shares of the firm’s stock in a transaction on Thursday, June 4th. The stock was purchased at an average price of $0.08 per share, with a total value of $67,489.76. Following the transaction, the insider owned 505,302 shares of the company’s stock, valued at approximately $40,424.16. This trade represents a -249.36% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Friday, June 5th, Financial Lp Hrt sold 735,462 shares of Aditxt stock. The shares were sold at an average price of $0.06, for a total value of $44,127.72.
• On Friday, April 24th, Financial Lp Hrt sold 1,089 shares of Aditxt stock. The shares were sold at an average price of $7.56, for a total value of $8,232.84.
• On Thursday, April 23rd, Financial Lp Hrt sold 141 shares of Aditxt stock. The shares were sold at an average price of $7.83, for a total value of $1,104.03.
• On Tuesday, April 21st, Financial Lp Hrt purchased 2,700 shares of Aditxt stock. The stock was acquired at an average cost of $8.91 per share, with a total value of $24,057.00.
• On Wednesday, April 22nd, Financial Lp Hrt sold 443 shares of Aditxt stock. The stock was sold at an average price of $8.10, for a total value of $3,588.30.

Aditxt Trading Down 19.6%

Shares of ADTX opened at $0.05 on Tuesday. Aditxt, Inc. has a 12 month low of $0.05 and a 12 month high of $53,451.08. The stock’s 50 day moving average is $7.33 and its two-hundred day moving average is $164.13. The firm has a market cap of $40,918.00, a P/E ratio of 0.00 and a beta of 0.84.

Aditxt (NASDAQ:ADTX) last announced its earnings results on Tuesday, March 31st. The company reported $315,563.31 earnings per share for the quarter. Aditxt had a negative return on equity of 374.60% and a negative net margin of 360,152.50%.

Wall Street Analyst Weigh In

ADTX has been the topic of several recent analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aditxt in a report on Monday, April 20th. Wall Street Zen raised shares of Aditxt to a “sell” rating in a research note on Saturday, May 23rd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of “Sell”.

About Aditxt

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.